Antongiulio Faggiano

Pubblicazioni

Titolo Pubblicato in Anno
Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2022
Lipid metabolism and homeostasis in patients with neuroendocrine neoplasms: from risk factor to potential therapeutic target METABOLITES 2022
Neuroendocrine Tumors. A Comprehensive Review on Nutritional Approaches CANCERS 2022
4BNT162b2 mRNA COVID-19 vaccine and semen: What do we know? ANDROLOGY 2022
The Role of Antihyperglycemic Drugs and Diet on Erectile Function: Results from a Perspective Study on a Population with Prediabetes and Diabetes JOURNAL OF CLINICAL MEDICINE 2022
Gestational Diabetes Mellitus pregnancy by pregnancy. early, late and nonrecurrent GDM DIABETES RESEARCH AND CLINICAL PRACTICE 2022
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours JOURNAL OF NEUROENDOCRINOLOGY 2022
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors ENDOCRINE 2022
Letter to the editor. how the COVID-19 pandemic has changed outpatient diagnosis in the andrological setting JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
Understanding care relationships in diabetes practice. A psychodynamic interview-based exploratory study PLOS ONE 2022
Mitotane treatment in adrenocortical carcinoma: mechanisms of action and predictive markers of response to therapy MINERVA ENDOCRINOLOGY 2022
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2022
New Prognostic Frontiers for Lung Neuroendocrine Tumors ANNALS OF ONCOLOGY 2022
Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications FRONTIERS IN ENDOCRINOLOGY 2021
Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: a systematic review CANCERS 2021
Immune Checkpoint Inhibitors. New Weapons Against Medullary Thyroid Cancer? FRONTIERS IN ENDOCRINOLOGY 2021
Case Report. Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers FRONTIERS IN ENDOCRINOLOGY 2021
Sunitinib treatment for advanced paraganglioma: case report of a novel SDHD gene mutation variant and systematic review of the literature FRONTIERS IN ONCOLOGY 2021
Pathology reporting in neuroendocrine neoplasms of the digestive system: everything you always wanted to know but were too afraid to ask FRONTIERS IN ENDOCRINOLOGY 2021
NETest: a systematic review focusing on the prognostic and predictive role NEUROENDOCRINOLOGY 2021

ERC

  • LS2_1
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_12
  • LS7_4
  • LS7_8
  • LS7_10
  • LS7_14

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

La principale area di ricerca sono è l'endocrinologia oncologica con numerose pubblicazioni e progetti clinici e traslazionali sulle neoplasie neuroendocrine, le neoplasie tiroidee, l'iperparatiroidismo, i tumori ipofisari, i feocromocitomi e paragangliomi, le sindromi neoplastiche genetiche multiendocrine. In tale ambito l'interesse di ricerca va dagli studi epidemiologici e di valutazione di fattori prognostici clinici e molecolari, studi sul ruolo della sindrome metabolica, della nutrizione e dei fatoori ambientali sulle neoplasie endocrine e neuroendocrine, studi genetici (ricerca nuove mutazioni, VUS, screening genetico, analisi NGS), studi diagnostici sulla diagnosi biochimica e ormonale e la diagnosi di imaging, studi terapeutici sull'efficacia e tossicità di farmaci biologici come analoghi della somatostatina, dopamino-agonisti, inibitori di mTOR, inibitori tirosino-chinasici. Più di recente interesse per l'andrologia, i tumori testicolari e le malattie genetiche della sfera andrologica

Keywords

neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma